\-\ Texto\\:\\ \ \(0\)\
\-\ epstein\\-barr\\ virus\\ igg\\ positive\\ with\\ titers\\ \\>1\\:2560\ \(0\)\
\-\ epstein\\-barr\\ virus\\ igm\\ negative\\	\ \(0\)\
\-\ heterophile\\ antibody\\ positive\ \(0\)\
\-\ he\\ was\\ treated\\ with\\ external\\ beam\\ radiation\\ therapy\\.\ \(0\)\
\-\ axial\\ ct\\ through\\ level\\ of\\ nasopharynx\ \(0\)\
\-\ asymmetry\\ of\\ the\\ soft\\ tissues\\ with\\ slight\\ increase\\ in\\ attenuation\\ in\\ the\\ left\\ lateral\\ nasopharyngeal\\ recess\\ \\(aka\\ fossa\\ of\\ rosenmuller\\)\ \(0\)\
\-\ well\\ circumscribed\\ hyperattenuated\\ soft\\ tissue\\ mass\\ in\\ location\\ of\\ lymph\\ nodes\\ \\(node\\ of\\ rouvierre\\)\ \(0\)\
\-\ axial\\ ct\\ through\\ level\\ of\\ nasopharynx\ \(0\)\
\-\ obliteration\\ of\\ the\\ normal\\ fat\\ planes\\ in\\ the\\ pterygopalatine\\ fossa\ \(0\)\
\-\ sagittal\\ t1\\ at\\ midline\ \(0\)\
\-\ nasopharyngeal\\ fullness\\,\\ convex\\ rather\\ than\\ concave\\ toward\\ brain\ \(0\)\
\-\ replacement\\ of\\ normal\\ t1\\-bright\\ marrow\\ signal\\ in\\ clivus\ \(0\)\
\-\ some\\ opacification\\ of\\ the\\ sphenoid\\ sinus\ \(0\)\
\-\ sagittal\\ t1\\ at\\ midline\ \(0\)\
\-\ sphenoid\\ opacified\ \(0\)\
\-\ posterior\\ to\\ maxilla\\ and\\ anterior\\ to\\ sphenoid\\ bone\\ is\\ pterygopalatine\\ fossa\\,\\ which\\ appears\\ to\\ be\\ full\\ of\\ a\\ soft\\ tissue\\ density\\ \ \(0\)\
\-\ able\\ to\\ see\\ foramen\\ rotundum\\,\\ widened\\ with\\ mass\\ filling\\ foramen\\ \ \(0\)\
\-\ axial\\ t2\\ through\\ the\\ level\\ of\\ the\\ orbits\ \(0\)\
\-\ sphenoid\\ is\\ opacified\\ with\\ t2\\ bright\\ signal\\,\\ consistent\\ with\\ mucus\\ secondary\\ to\\ mass\\ blocking\\ outflow\\ of\\ sinus\ \(0\)\
\-\ axial\\ spgr\\ fat\\-saturated\\ post\\-contrast\\ \\(t1\\ spin\\ gradient\\ technique\\)\ \(0\)\
\-\ enlarged\\ and\\ enhancing\\ nodes\\ of\\ left\\ anterior\\ cervical\\ chain\\ and\\ skull\\ base\\,\\ including\\ node\\ of\\ rouvierre\ \(0\)\
\-\ coronal\\ t1\\ post\\-gadolinium\\ fat\\-saturated\\ at\\ the\\ nasopharynx\ \(0\)\
\-\ can\\ see\\ extension\\ through\\ foramen\\ ovale\ \(0\)\
\-\ some\\ enhancing\\ opacification\\ of\\ inferior\\ sphenoid\\ sinus\ \(0\)\
\-\ loss\\ of\\ fat\\ planes\\ in\\ area\\ of\\ levator\\/tensor\\ veli\\ palatini\\ and\\ pterygoid\\ muscles\ \(0\)\
\-\ nasopharyngeal\\ carcinoma\ \(1\)\
\-\ nasopharyngeal\\ tumors\\ \\(e\\.g\\.\\,\\ squamous\\ cell\\ carcinoma\\,\\ nasopharyngeal\\ carcinoma\\,\\ lymphoma\\,\\ minor\\ salivary\\ gland\\ tumor\\,\\ rhabdomyosarcoma\\,\\ juvenile\\ angiofibroma\\)\ \(0\)\
\-\ malignant\\ ottitis\\ externa\ \(0\)\
\-\ benign\\ adenoidal\\ hypertrophy\ \(0\)\
\-\ abscess\ \(594\)\
\-\ mucocele\ \(25\)\
\-\ nasal\\ polyps\ \(1\)\
\-\ 35\\ yo\\ korean\\ man\\ with\\ a\\ 4\\.5\\ month\\ history\\ of\\ left\\ cervical\\ lymphadenopathy\\ not\\ responsive\\ to\\ antibiotics\\.\\ \\ the\\ patient\\ also\\ reports\\ a\\ 6\\ week\\ history\\ of\\ left\\ facial\\ parasthesias\\ and\\ occasional\\ left\\ sided\\ epistaxis\\ and\\ sinusitis\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ nasopharyngeal\\:\\ 0\\.31590309431491004\ \(0\)\
\-\ sphenoid\\:\\ 0\\.2638091572182876\ \(0\)\
\-\ of\\:\\ 0\\.19502547707999646\ \(0\)\
\-\ nasopharynx\\:\\ 0\\.18812693825600924\ \(0\)\
\-\ rouvierre\\:\\ 0\\.1677622834399335\ \(0\)\
\-\ t1\\:\\ 0\\.16340237143354486\ \(0\)\
\-\ pterygopalatine\\:\\ 0\\.15091178254036566\ \(0\)\
\-\ foramen\\:\\ 0\\.13987550554747322\ \(0\)\
\-\ fat\\:\\ 0\\.13051192618820082\ \(0\)\
\-\ opacified\\:\\ 0\\.1254179588373395\ \(0\)\
\-\ through\\:\\ 0\\.12489217747431837\ \(0\)\
\-\ fossa\\:\\ 0\\.12352855347961769\ \(0\)\
\-\ axial\\:\\ 0\\.12119116467407681\ \(0\)\
\-\ virus\\:\\ 0\\.12059310454095105\ \(0\)\
\-\ sinus\\:\\ 0\\.1137029903076011\ \(0\)\
\-\ planes\\:\\ 0\\.10820328947304696\ \(0\)\
\-\ opacification\\:\\ 0\\.10086741402293786\ \(0\)\
\-\ bright\\:\\ 0\\.09563756043207722\ \(0\)\
\-\ level\\:\\ 0\\.09505096756279932\ \(0\)\
\-\ the\\:\\ 0\\.09419352008633193\ \(0\)\
\-\ carcinoma\\:\\ 0\\.09412209664600361\ \(0\)\
\-\ node\\:\\ 0\\.09016593120315403\ \(0\)\
\-\ left\\:\\ 0\\.08946151258007323\ \(0\)\
\-\ nodes\\:\\ 0\\.0891147933161016\ \(0\)\
\-\ hyperattenuated\\:\\ 0\\.08388114171996675\ \(0\)\
\-\ palatini\\:\\ 0\\.08388114171996675\ \(0\)\
\-\ ottitis\\:\\ 0\\.08388114171996675\ \(0\)\
\-\ adenoidal\\:\\ 0\\.08388114171996675\ \(0\)\
\-\ soft\\:\\ 0\\.08377196210834581\ \(0\)\
\-\ sagittal\\:\\ 0\\.08066403673829153\ \(0\)\
\-\ spgr\\:\\ 0\\.08015290900340012\ \(0\)\
\-\ midline\\:\\ 0\\.07889663228873874\ \(0\)\
\-\ to\\:\\ 0\\.07867642030437481\ \(0\)\
\-\ in\\:\\ 0\\.07828917512658115\ \(0\)\
\-\ rosenmuller\\:\\ 0\\.07750768579421019\ \(0\)\
\-\ externa\\:\\ 0\\.07750768579421019\ \(0\)\
\-\ rotundum\\:\\ 0\\.07545589127018283\ \(0\)\
\-\ veli\\:\\ 0\\.07545589127018283\ \(0\)\
\-\ cervical\\:\\ 0\\.07513319596193388\ \(0\)\
\-\ korean\\:\\ 0\\.07377945307764358\ \(0\)\
\-\ blocking\\:\\ 0\\.07236204478203345\ \(0\)\
\-\ with\\:\\ 0\\.07189442280487147\ \(0\)\
\-\ parasthesias\\:\\ 0\\.07113422986845366\ \(0\)\
\-\ titers\\:\\ 0\\.07005122036107696\ \(0\)\
\-\ positive\\:\\ 0\\.06912550350767539\ \(0\)\
\-\ pterygoid\\:\\ 0\\.06908243534442629\ \(0\)\
\-\ ovale\\:\\ 0\\.06667000819623208\ \(0\)\
\-\ igm\\:\\ 0\\.06598858885627691\ \(0\)\
\-\ concave\\:\\ 0\\.06598858885627691\ \(0\)\
\-\ enhancing\\:\\ 0\\.06571529299504994\ \(0\)\
\-\ angiofibroma\\:\\ 0\\.06535420262785967\ \(0\)\
\-\ epistaxis\\:\\ 0\\.06535420262785967\ \(0\)\
\-\ see\\:\\ 0\\.06525596309410041\ \(0\)\
\-\ and\\:\\ 0\\.0650305870545635\ \(0\)\
\-\ aka\\:\\ 0\\.06420333337884664\ \(0\)\
\-\ maxilla\\:\\ 0\\.062260356139710295\ \(0\)\
\-\ igg\\:\\ 0\\.061832606770413315\ \(0\)\
\-\ recess\\:\\ 0\\.061832606770413315\ \(0\)\
\-\ clivus\\:\\ 0\\.061832606770413315\ \(0\)\
\-\ salivary\\:\\ 0\\.061832606770413315\ \(0\)\
\-\ beam\\:\\ 0\\.06142387489136487\ \(0\)\
\-\ chain\\:\\ 0\\.06142387489136487\ \(0\)\
\-\ convex\\:\\ 0\\.0610325412261305\ \(0\)\
\-\ outflow\\:\\ 0\\.0610325412261305\ \(0\)\
\-\ t2\\:\\ 0\\.06035342937423432\ \(0\)\
\-\ mucus\\:\\ 0\\.06029655227047553\ \(0\)\
\-\ mass\\:\\ 0\\.060105056800271096\ \(0\)\
\-\ antibody\\:\\ 0\\.05994953171875381\ \(0\)\
\-\ responsive\\:\\ 0\\.05961513293052037\ \(0\)\
\-\ signal\\:\\ 0\\.05946636830896839\ \(0\)\
\-\ at\\:\\ 0\\.05943462692249435\ \(0\)\
\-\ orbits\\:\\ 0\\.059292469885114794\ \(0\)\
\-\ spin\\:\\ 0\\.058980746702103126\ \(0\)\
\-\ anterior\\:\\ 0\\.05857154770006888\ \(0\)\
\-\ polyps\\:\\ 0\\.05656831955390891\ \(0\)\
\-\ widened\\:\\ 0\\.055670538390143326\ \(0\)\
\-\ gradient\\:\\ 0\\.05505041896560832\ \(0\)\
\-\ tissue\\:\\ 0\\.05502960137741123\ \(0\)\
\-\ technique\\:\\ 0\\.05410164473652348\ \(0\)\
\-\ sinusitis\\:\\ 0\\.05410164473652348\ \(0\)\
\-\ toward\\:\\ 0\\.05374794908232536\ \(0\)\
\-\ fullness\\:\\ 0\\.0534073563206294\ \(0\)\
\-\ rhabdomyosarcoma\\:\\ 0\\.053078930220658856\ \(0\)\
\-\ juvenile\\:\\ 0\\.051592645548632486\ \(0\)\
\-\ occasional\\:\\ 0\\.050555496252319206\ \(0\)\
\-\ hypertrophy\\:\\ 0\\.04940462700330618\ \(0\)\
\-\ minor\\:\\ 0\\.049297082464386785\ \(0\)\
\-\ squamous\\:\\ 0\\.04720261986724072\ \(0\)\
\-\ rather\\:\\ 0\\.04646663091158575\ \(0\)\
\-\ slight\\:\\ 0\\.04593233396241377\ \(0\)\
\-\ muscles\\:\\ 0\\.044948730323285155\ \(0\)\
\-\ marrow\\:\\ 0\\.04358861164140011\ \(0\)\
\-\ facial\\:\\ 0\\.043250108879317066\ \(0\)\
\-\ normal\\:\\ 0\\.04283107635014595\ \(0\)\
\-\ gland\\:\\ 0\\.042608340110754206\ \(0\)\
\-\ skull\\:\\ 0\\.042556827632848106\ \(0\)\
\-\ external\\:\\ 0\\.04240399940678569\ \(0\)\
\-\ lymphadenopathy\\:\\ 0\\.04240399940678569\ \(0\)\
\-\ increase\\:\\ 0\\.04210575856234414\ \(0\)\
\-\ 35\\:\\ 0\\.04205697885506397\ \(0\)\
\-\ coronal\\:\\ 0\\.04176961317836845\ \(0\)\
\-\ tissues\\:\\ 0\\.04135473288501039\ \(0\)\
\-\ full\\:\\ 0\\.041001037230812276\ \(0\)\
\-\ lymph\\:\\ 0\\.04078669295023703\ \(0\)\
\-\ reports\\:\\ 0\\.04078669295023703\ \(0\)\
\-\ circumscribed\\:\\ 0\\.040618743929355425\ \(0\)\
\-\ filling\\:\\ 0\\.040618743929355425\ \(0\)\
\-\ attenuation\\:\\ 0\\.04013255386082396\ \(0\)\
\-\ history\\:\\ 0\\.04007891116328726\ \(0\)\
\-\ ct\\:\\ 0\\.03993744964639769\ \(0\)\
\-\ base\\:\\ 0\\.03989877126978521\ \(0\)\
\-\ antibiotics\\:\\ 0\\.03864214707961192\ \(0\)\
\-\ tumors\\:\\ 0\\.038575274397528614\ \(0\)\
\-\ appears\\:\\ 0\\.038410190012481235\ \(0\)\
\-\ including\\:\\ 0\\.037536792595849994\ \(0\)\
\-\ extension\\:\\ 0\\.03712935459610537\ \(0\)\
\-\ location\\:\\ 0\\.03652347987350124\ \(0\)\
\-\ inferior\\:\\ 0\\.035683522929307425\ \(0\)\
\-\ week\\:\\ 0\\.035279022506043464\ \(0\)\
\-\ density\\:\\ 0\\.034780651838338845\ \(0\)\
\-\ radiation\\:\\ 0\\.03475862798767204\ \(0\)\
\-\ area\\:\\ 0\\.03397874895700178\ \(0\)\
\-\ sided\\:\\ 0\\.03373938741678574\ \(0\)\
\-\ yo\\:\\ 0\\.032768633670171986\ \(0\)\
\-\ brain\\:\\ 0\\.03269803867267535\ \(0\)\
\-\ treated\\:\\ 0\\.03266294338862937\ \(0\)\
\-\ negative\\:\\ 0\\.03247227777136286\ \(0\)\
\-\ month\\:\\ 0\\.03190676791936185\ \(0\)\
\-\ lymphoma\\:\\ 0\\.03123803207076905\ \(0\)\
\-\ secondary\\:\\ 0\\.03108924317282092\ \(0\)\
\-\ he\\:\\ 0\\.031059772143561454\ \(0\)\
\-\ therapy\\:\\ 0\\.030136707575746862\ \(0\)\
\-\ cell\\:\\ 0\\.030004593905607974\ \(0\)\
\-\ than\\:\\ 0\\.029733184154484196\ \(0\)\
\-\ is\\:\\ 0\\.02872832202892419\ \(0\)\
\-\ bone\\:\\ 0\\.02861909626882483\ \(0\)\
\-\ consistent\\:\\ 0\\.0284403309151332\ \(0\)\
\-\ man\\:\\ 0\\.027768400691868925\ \(0\)\
\-\ tumor\\:\\ 0\\.027435103953526836\ \(0\)\
\-\ lateral\\:\\ 0\\.026030457565943715\ \(0\)\
\-\ also\\:\\ 0\\.024671616049594086\ \(0\)\
\-\ which\\:\\ 0\\.023850154799482895\ \(0\)\
\-\ be\\:\\ 0\\.02127741945128403\ \(0\)\
\-\ not\\:\\ 0\\.020706548842475254\ \(0\)\
\-\ was\\:\\ 0\\.018279817901003862\ \(0\)\
\-\ patient\\:\\ 0\\.01705979396181677\ \(0\)\
